Rethinking Prognosis and Therapy for Follicular Lymphoma

Affiliations

¹ Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA cajacobson@partners.org.
² Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA.

Editorial

Caron A Jacobson et al. J Clin Oncol. 2015.

. 2015 Aug 10;33(23):2489-91.

doi: 10.1200/JCO.2015.62.3256. Epub 2015 Jul 13.

¹ Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA cajacobson@partners.org.
² Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA.

No abstract available

Comment on

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, Hainsworth JD, Maurer MJ, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW. Casulo C, et al. J Clin Oncol. 2015 Aug 10;33(23):2516-22. doi: 10.1200/JCO.2014.59.7534. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124482 Free PMC article.